HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Acute thrombosis of lower extremities. Risk factors, methods of prevention and treatment].

Abstract
The results of treatment of 526 patients with an acute venous thrombosis of the lower extremities aged from 23 to 70 years, including 140 (36.3%) men and 376 (63.7%) women, were analyzed. The main etiological factors of thrombosis were physical overload, operations with subsequent immobilization, trauma of lower extremities, pregnancy and delivery, tumor of small pelvis and of other localization. In 65 patients an acute venous thrombosis was complicated by thromboembolism of pulmonary artery (TEPA), 2 patients died before initiation of treatment. Conduction of conservative therapy in 314 (94.4%) patients with thrombosis of the lower extremities deep veins using fraxiparine (fraxiparine forte) have allowed to achieve considerable improvement of their state. In 80 patients with thrombosis of subcutaneous veins was performed ligature of mouth for prophylaxis of TEPA, in all of them good clinical result was noted. High efficacy of fraxiparine application in prophylactical dosage for prevention of the venous thromboembolism occurrence was noted.
AuthorsA B Gubka, V I Pertsov, V A Gubka, L P Karnaukh, D A Buga
JournalKlinichna khirurhiia (Klin Khir) Issue 3 Pg. 44-8 (Mar 2003) ISSN: 0023-2130 [Print] Ukraine
Vernacular TitleOstryĭ tromboz nizhnikh konechnosteĭ. Faktory riska, metody profilaktiki i lecheniia.
PMID12833616 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Fibrinolytic Agents
Topics
  • Acute Disease
  • Adult
  • Aged
  • Female
  • Fibrinolytic Agents (therapeutic use)
  • Humans
  • Lower Extremity (blood supply)
  • Male
  • Middle Aged
  • Risk Factors
  • Venous Thrombosis (drug therapy, etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: